Pre-IPO Advisors

xAI equity: two groups of employees, one complicated picture.

xAI employees hold direct grants in the company building Grok. X Corp employees who kept equity through the Musk acquisition received xAI shares in the reported 2025 merger. The two groups face different questions — but both are navigating equity in a high-growth, still-private AI company with no public market yet.

What's publicly known

  • xAI was founded in March 2023 by Elon Musk to develop Grok, a large language model integrated with X. From a standing start, xAI scaled quickly — raising at a reported ~$24B in 2024 and a reported ~$50B shortly after, among the fastest private-company valuations in AI.
  • In March 2025, xAI and X Corp agreed to merge. Under the reported deal, X Corp became part of xAI; X shareholders received roughly 25% of the combined entity. The deal valued xAI at a reported ~$80B and X at a reported ~$33B, for a combined ~$113B — giving X equity holders xAI shares at the merger ratio.
  • X Corp employees who held equity through the October 2022 privatization (or who received X Corp grants after it) had their positions converted in the merger. What you received depends on your grant documents, the exchange ratio, and the merger terms — none of which are standardized by this page.
  • No public listing announced. As of mid-2026, xAI is private. There is no Nasdaq or NYSE ticker; "what it's worth" is whatever the most recent reported round or liquidity window implies.
  • Programs and terms change. xAI's structure, valuation, and equity program have evolved rapidly. Verify everything against your own grant documents and any company communications you receive — reported figures are snapshots, not promises.

Educational only. This site is not affiliated with, sponsored by, or endorsed by xAI or X Corp. Company names and trademarks belong to their respective owners. Figures are from public reporting and may simplify holder-class differences.

Two groups with different starting points

If you're a direct xAI employee

Your equity is in the company you joined — likely stock options or RSUs in xAI. The standard planning questions apply: what's the vesting schedule, what's the 409A strike versus the preferred-round price, and when (if ever) is there a liquidity window? The company has grown fast, which means spreads on early grants can be large — and ISO exercises before a potential listing carry meaningful AMT risk. The ISO/AMT estimator can size the exposure before you commit to an exercise.

If you're an X Corp employee who received xAI equity

Your situation has more layers. You came in through X Corp — possibly from the pre-2022 Twitter era, or from a post-acquisition X grant — and the March 2025 merger converted that X position into xAI shares. Two things to work through before planning a sale:

  1. What's your basis and holding period? The merger may have reset your cost basis and your holding-period clock depending on how it was structured (tax-free reorganization vs. taxable exchange). This is not something to guess at — your CPA needs the merger documents. The difference between a tax-free and a taxable exchange is the difference between deferring the gain and owing it now.
  2. What did you actually receive? The exchange ratio in the merger determines how many xAI shares (or units) your X position became. That ratio, combined with xAI's current 409A or preferred valuation, gives you a rough position size — but verify the share count against your account statement, not reported headlines.

The planning questions that matter now

  1. Has there been a liquidity window? xAI has reported raising secondary rounds; employee access to those windows varies by grant class and company policy. Read any tender or secondary communications the company has sent you — those define the actual opportunity.
  2. How concentrated is your net worth in this one position? AI companies at $50B+ valuations can move sharply in both directions. If xAI represents the majority of your household's net worth and there's no public market, you're carrying illiquid concentration risk. That's a planning problem independent of whether the position keeps growing.
  3. What's the exercise math if you hold options? If your xAI equity is options rather than shares, the decision to exercise — especially ISOs — should be modeled before a window or IPO puts time pressure on it. AMT, exercise cost, and holding-period planning are all pre-event decisions. Use the ISO/AMT calculator to see your exposure and start with the early exercise and 83(b) guide.
  4. What does the liquidation waterfall look like? In any liquidity event — tender, secondary, or IPO — common shareholders and optionholders typically sit below preferred investors in the distribution stack. Your payout depends on the size of the exit and the preferred stack above you. Understanding this is basic to modeling how much you'd actually net.

If an IPO comes

No timeline has been announced, but rapid AI growth and the combined xAI/X entity's scale makes a listing a plausible eventual outcome. If xAI files to go public:

Not an employee — looking to invest?

xAI is private; there's no public stock. Reported secondary access for accredited investors exists through institutional funds and SPVs at terms we don't have visibility into. We don't sell or arrange investments — this page is for employees and holders planning what they already own. For comparable pre-IPO AI company situations, see Anthropic or OpenAI.

Two companies merged into your net worth. Get it untangled.

Get matched with a fee-only fiduciary who works complex equity — merger basis questions, AMT modeling, liquidity window planning, and concentration. Free, no obligation.